Holak, Tad A.

Lifeact: a versatile marker to visualize F-actin

Riedl, J., Crevenna, A. H., Kessenbrock, K., Yu, J. H., Neukirchen, D., Bista, M., Bradke, F., Jenne, D., Holak, T. A., Werb, Z., et al. (2008) · Nature Methods

Cellular Mechanics and InteractionsAdvanced Fluorescence Microscopy Techniques

Cited by 2,189

Structure of the Stapled p53 Peptide Bound to Mdm2

Baek, S., Kutchukian, P. S., Verdine, G. L., Huber, R., Holak, T. A., Lee, K. W., & Popowicz, G. M. (2012) · Journal of the American Chemical Society

Cancer-related Molecular PathwaysChemical Synthesis and Analysis

Cited by 259

c-Abl Phosphorylates Hdmx and Regulates Its Interaction with p53

Zuckerman, V., Lenos, K., Popowicz, G. M., Silberman, I., Grossman, T., Marine, J.-C., Holak, T. A., Jochemsen, A. G., & Haupt, Y. (2009) · Journal of Biological Chemistry

Cancer-related Molecular PathwaysHeat shock proteins research

Cited by 68

Exhaustive Fluorine Scanning toward Potent p53–Mdm2 Antagonists

Huang, Y., Wolf, S., Koes, D., Popowicz, G. M., Camacho, C. J., Holak, T. A., & Dömling, A. (2012) · ChemMedChem

Cancer-related Molecular PathwaysFluorine in Organic Chemistry

Cited by 49

Helping the released guardian: Drug combinations for supporting the anticancer activity of HDM2 (MDM2) antagonists

Kocik, J., Machula, M., Wisniewska, A., Surmiak, E., Holak, T. A., & Skalniak, L. (2019) · Cancers

Cancer-related Molecular PathwaysHeat shock proteins research

Cited by 46

Hitting on the move: targeting intrinsically disordered protein states of the MDM2-p53 interaction

Neochoritis, C. G., Atmaj, J., Twarda-Clapa, A., Surmiak, E., Skalniak, L., Köhler, L.-M., Muszak, D., Kurpiewska, K., Kalinowska-Tłuścik, J., Beck, B., et al. (2019) · European Journal of Medicinal Chemistry

Cancer-related Molecular PathwaysProtein Structure and Dynamics

Cited by 12